These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2194597)
1. Bone marrow transplantation utilizing HLA-matched unrelated marrow donors. Gajewski J; Cecka M; Champlin R Blood Rev; 1990 Jun; 4(2):132-8. PubMed ID: 2194597 [No Abstract] [Full Text] [Related]
2. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Beatty PG; Hansen JA; Longton GM; Thomas ED; Sanders JE; Martin PJ; Bearman SI; Anasetti C; Petersdorf EW; Mickelson EM Transplantation; 1991 Feb; 51(2):443-7. PubMed ID: 1994541 [TBL] [Abstract][Full Text] [Related]
3. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of graft failure after human marrow transplantation: a review. Hows JM Immunol Lett; 1991 Jul; 29(1-2):77-80. PubMed ID: 1916930 [TBL] [Abstract][Full Text] [Related]
5. The immunogenetics of bone marrow transplantation. Beatty PG Transfus Med Rev; 1994 Jan; 8(1):45-58. PubMed ID: 8136607 [TBL] [Abstract][Full Text] [Related]
6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
7. Selection of marrow donors for patients lacking an HLA-identical sibling. Anasetti C; Beatty PG Cancer Treat Res; 1990; 50():129-40. PubMed ID: 1976347 [No Abstract] [Full Text] [Related]
8. Histocompatibility and bone marrow transplantation (BMT). Richter KV Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191 [TBL] [Abstract][Full Text] [Related]
10. HLA-mismatched bone marrow transplantation in thalassemia. Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569 [No Abstract] [Full Text] [Related]
11. Results of allogeneic bone marrow transplantation with unrelated or mismatched donors. Beatty PG Semin Oncol; 1992 Jun; 19(3 Suppl 7):13-9. PubMed ID: 1615329 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for patients with hematologic malignancies. Buckner CD; Anasetti C; Bianco J; Nemunaitis J Schweiz Med Wochenschr Suppl; 1991; 43():91-101. PubMed ID: 1726858 [TBL] [Abstract][Full Text] [Related]
14. Significance of MLC for BMT with serological HLA-identical related and unrelated donors. Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540 [No Abstract] [Full Text] [Related]
15. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients]. Egeland T; Thorsby E Tidsskr Nor Laegeforen; 1994 Jan; 114(3):319-22. PubMed ID: 8191429 [TBL] [Abstract][Full Text] [Related]
16. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [TBL] [Abstract][Full Text] [Related]
18. Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre. Vossen JM; Donker AE; Heemskerk MB; Lie JL; van Weel-Sipman MH; Bredius RG; Bakker JD; Egeler RM; Oudshoorn M Bone Marrow Transplant; 2010 Jan; 45(1):87-95. PubMed ID: 19448680 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors. Champlin R Bone Marrow Transplant; 1993; 11 Suppl 1():74-7. PubMed ID: 8448555 [No Abstract] [Full Text] [Related]
20. Bone marrow transplantation in leukemia using family donors other than HLA-identical siblings: a preliminary report from the International Bone Marrow Transplant Registry. Bortin MM Transplant Proc; 1987 Feb; 19(1 Pt 3):2629-31. PubMed ID: 3274571 [No Abstract] [Full Text] [Related] [Next] [New Search]